Free Trial

William Blair Has Positive Outlook for SunOpta Q3 Earnings

SunOpta logo with Consumer Staples background

SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY - William Blair boosted their Q3 2025 earnings estimates for shares of SunOpta in a report issued on Thursday, May 8th. William Blair analyst J. Andersen now expects that the company will post earnings per share of $0.05 for the quarter, up from their previous estimate of $0.04. The consensus estimate for SunOpta's current full-year earnings is $0.13 per share. William Blair also issued estimates for SunOpta's Q4 2025 earnings at $0.09 EPS and FY2026 earnings at $0.28 EPS.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its earnings results on Wednesday, May 7th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The firm had revenue of $201.63 million for the quarter, compared to analyst estimates of $195.09 million. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%.

Separately, StockNews.com raised SunOpta from a "sell" rating to a "hold" rating in a report on Tuesday, March 11th.

Get Our Latest Stock Analysis on SunOpta

SunOpta Price Performance

NASDAQ:STKL traded up $0.23 during mid-day trading on Friday, reaching $6.06. 2,383,959 shares of the stock were exchanged, compared to its average volume of 763,338. The business has a fifty day moving average price of $4.71 and a 200 day moving average price of $6.44. The firm has a market capitalization of $725.72 million, a PE ratio of -33.66 and a beta of 1.50. SunOpta has a 1-year low of $3.65 and a 1-year high of $8.11. The company has a current ratio of 1.20, a quick ratio of 0.53 and a debt-to-equity ratio of 1.61.

Hedge Funds Weigh In On SunOpta

Institutional investors have recently bought and sold shares of the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new position in SunOpta in the 4th quarter worth about $733,000. Barclays PLC increased its stake in SunOpta by 103.3% in the 3rd quarter. Barclays PLC now owns 178,954 shares of the company's stock worth $1,142,000 after purchasing an additional 90,937 shares in the last quarter. JPMorgan Chase & Co. increased its stake in SunOpta by 12.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 515,170 shares of the company's stock worth $3,287,000 after purchasing an additional 56,621 shares in the last quarter. Raymond James Financial Inc. purchased a new position in SunOpta in the 4th quarter worth about $1,289,000. Finally, Harbor Capital Advisors Inc. increased its stake in SunOpta by 65.6% in the 4th quarter. Harbor Capital Advisors Inc. now owns 1,761,922 shares of the company's stock worth $13,567,000 after purchasing an additional 698,004 shares in the last quarter. Hedge funds and other institutional investors own 85.39% of the company's stock.

Insider Buying and Selling

In related news, SVP Bryan P. Clark sold 8,500 shares of SunOpta stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the transaction, the senior vice president now owns 28,150 shares of the company's stock, valued at approximately $149,758. This trade represents a 23.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is currently owned by company insiders.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Further Reading

Should You Invest $1,000 in SunOpta Right Now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines